JACLYN LANCIANO: Open Payments
NPI 1417514357 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 55 payments from 13 companies in 2025. Trend: 2023 $161 · 2024 $1,213 · 2025 $1,097
Food & beverage: $1,090Education: $7
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $271 |
| Galderma Laboratories, L.P. | 5 | $181 |
| Regeneron Healthcare Solutions, Inc. | 5 | $163 |
| Organon LLC | 21 | $144 |
| UCB, Inc. | 6 | $106 |
| Lilly USA, LLC | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Botanix SB Inc | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Almirall LLC | 2 | $31 |
Products named: OTEZLA, NEMLUVIO, DUPIXENT, Bimzelx, VTAMA, Sotyktu, SOFDRA, Seysara.
Industry payments across NJ — which companies pay providers there.
